Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients With Refractory Solid Malignancies: An Interventional Molecular Profiling Study

Oncologist - United States
doi 10.1634/theoncologist.2018-0263